Niger
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 8.73 (8.43 - 9.03) | 2019 | Modelled | IHME |
| 9.46 (9.18 - 9.74) | 2018 | Modelled | IHME |
| 9.88 (9.58 - 10.22) | 2017 | Modelled | IHME |
| 10.02 (9.73 - 10.32) | 2016 | Modelled | IHME |
| 10.13 (9.80 - 10.47) | 2015 | Modelled | IHME |
| 10.36 (10.02 - 10.71) | 2014 | Modelled | IHME |
| 10.69 (10.33 - 11.07) | 2013 | Modelled | IHME |
| 11.07 (10.68 - 11.49) | 2012 | Modelled | IHME |
| 11.47 (11.03 - 11.92) | 2011 | Modelled | IHME |
| 11.84 (11.34 - 12.35) | 2010 | Modelled | IHME |
| 12.21 (11.70 - 12.73) | 2009 | Modelled | IHME |
| 12.62 (12.07 - 13.19) | 2008 | Modelled | IHME |
| 13.01 (12.40 - 13.63) | 2007 | Modelled | IHME |
| 13.33 (12.64 - 13.98) | 2006 | Modelled | IHME |
| 13.51 (12.75 - 14.22) | 2005 | Modelled | IHME |
| 13.6 (12.89 - 14.29) | 2004 | Modelled | IHME |
| 13.66 (12.99 - 14.33) | 2003 | Modelled | IHME |
| 13.71 (13.05 - 14.40) | 2002 | Modelled | IHME |
| 13.76 (13.08 - 14.46) | 2001 | Modelled | IHME |
| 13.82 (13.09 - 14.57) | 2000 | Modelled | IHME |
| 13.9 (13.24 - 14.59) | 1999 | Modelled | IHME |
| 14 (13.36 - 14.65) | 1998 | Modelled | IHME |
| 14.1 (13.49 - 14.74) | 1997 | Modelled | IHME |
| 14.21 (13.55 - 14.83) | 1996 | Modelled | IHME |
| 14.31 (13.60 - 14.95) | 1995 | Modelled | IHME |
| 14.41 (13.75 - 15.02) | 1994 | Modelled | IHME |
| 14.51 (13.90 - 15.08) | 1993 | Modelled | IHME |
| 14.62 (14.01 - 15.20) | 1992 | Modelled | IHME |
| 14.72 (14.09 - 15.31) | 1991 | Modelled | IHME |
| 14.82 (14.17 - 15.46) | 1990 | Modelled | IHME |
| 11.61 (8.18 - 16.22) | 2015 | Modelled | WHO |
| 8.61 (14.38 - 16.65) | 2013 | Modelled | Schweitzer et al, 2015 |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 3.29 (2.77 - 3.72) | 2019 | Modelled | IHME |
| 3.4 (2.99 - 3.83) | 2018 | Modelled | IHME |
| 3.52 (3.08 - 3.98) | 2017 | Modelled | IHME |
| 3.66 (3.21 - 4.13) | 2016 | Modelled | IHME |
| 3.77 (3.25 - 4.25) | 2015 | Modelled | IHME |
| 3.8 (3.28 - 4.29) | 2014 | Modelled | IHME |
| 3.81 (3.30 - 4.34) | 2013 | Modelled | IHME |
| 3.83 (3.30 - 4.32) | 2012 | Modelled | IHME |
| 3.84 (3.31 - 4.31) | 2011 | Modelled | IHME |
| 3.87 (3.32 - 4.42) | 2010 | Modelled | IHME |
| 4.59 (3.93 - 5.21) | 2009 | Modelled | IHME |
| 6.26 (5.34 - 7.10) | 2008 | Modelled | IHME |
| 8.25 (7.07 - 9.34) | 2007 | Modelled | IHME |
| 9.92 (8.46 - 11.26) | 2006 | Modelled | IHME |
| 10.64 (8.96 - 12.26) | 2005 | Modelled | IHME |
| 10.67 (9.12 - 12.17) | 2004 | Modelled | IHME |
| 10.69 (9.20 - 12.19) | 2003 | Modelled | IHME |
| 10.7 (9.24 - 12.24) | 2002 | Modelled | IHME |
| 10.71 (9.22 - 12.36) | 2001 | Modelled | IHME |
| 10.73 (9.10 - 12.49) | 2000 | Modelled | IHME |
| 10.78 (9.33 - 12.44) | 1999 | Modelled | IHME |
| 10.87 (9.41 - 12.38) | 1998 | Modelled | IHME |
| 10.99 (9.51 - 12.40) | 1997 | Modelled | IHME |
| 11.11 (9.56 - 12.50) | 1996 | Modelled | IHME |
| 11.2 (9.51 - 12.58) | 1995 | Modelled | IHME |
| 11.28 (9.74 - 12.55) | 1994 | Modelled | IHME |
| 11.36 (9.92 - 12.59) | 1993 | Modelled | IHME |
| 11.44 (10 - 12.69) | 1992 | Modelled | IHME |
| 11.52 (10.04 - 12.83) | 1991 | Modelled | IHME |
| 11.59 (10.07 - 12.99) | 1990 | Modelled | IHME |
| 6.01 (3.77 - 9.44) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,188,920 (1,136,460 - 1,240,590) | 1990 | Modelled | IHME |
| 1,217,740 (1,165,930 - 1,266,480) | 1991 | Modelled | IHME |
| 1,247,960 (1,196,120 - 1,297,530) | 1992 | Modelled | IHME |
| 1,279,900 (1,225,500 - 1,329,680) | 1993 | Modelled | IHME |
| 1,313,700 (1,253,540 - 1,369,070) | 1994 | Modelled | IHME |
| 1,349,220 (1,282,410 - 1,409,500) | 1995 | Modelled | IHME |
| 1,386,540 (1,322,290 - 1,446,910) | 1996 | Modelled | IHME |
| 1,426,040 (1,363,840 - 1,490,170) | 1997 | Modelled | IHME |
| 1,467,730 (1,400,900 - 1,535,920) | 1998 | Modelled | IHME |
| 1,512,030 (1,440,170 - 1,587,060) | 1999 | Modelled | IHME |
| 1,559,420 (1,477,520 - 1,644,610) | 2000 | Modelled | IHME |
| 1,610,780 (1,531,360 - 1,693,210) | 2001 | Modelled | IHME |
| 1,665,920 (1,586,580 - 1,749,860) | 2002 | Modelled | IHME |
| 1,723,380 (1,638,580 - 1,808,560) | 2003 | Modelled | IHME |
| 1,781,690 (1,689,450 - 1,872,000) | 2004 | Modelled | IHME |
| 1,838,970 (1,735,170 - 1,935,660) | 2005 | Modelled | IHME |
| 1,884,140 (1,787,270 - 1,977,240) | 2006 | Modelled | IHME |
| 1,911,340 (1,821,350 - 2,002,510) | 2007 | Modelled | IHME |
| 1,926,700 (1,842,780 - 2,013,170) | 2008 | Modelled | IHME |
| 1,937,480 (1,857,270 - 2,020,240) | 2009 | Modelled | IHME |
| 1,951,760 (1,869,380 - 2,036,780) | 2010 | Modelled | IHME |
| 1,965,260 (1,890,710 - 2,042,660) | 2011 | Modelled | IHME |
| 1,971,480 (1,901,210 - 2,044,780) | 2012 | Modelled | IHME |
| 1,977,430 (1,910,970 - 2,047,580) | 2013 | Modelled | IHME |
| 1,991,330 (1,925,400 - 2,058,630) | 2014 | Modelled | IHME |
| 2,022,510 (1,956,200 - 2,090,730) | 2015 | Modelled | IHME |
| 2,077,410 (2,018,820 - 2,140,780) | 2016 | Modelled | IHME |
| 2,130,190 (2,064,310 - 2,202,880) | 2017 | Modelled | IHME |
| 2,118,630 (2,055,950 - 2,181,290) | 2018 | Modelled | IHME |
| 2,034,140 (1,962,920 - 2,102,530) | 2019 | Modelled | IHME |
| 351,023 (300,879 - 407,840) | 1990 | Modelled | IHME |
| 355,337 (305,072 - 408,948) | 1991 | Modelled | IHME |
| 360,240 (311,607 - 411,753) | 1992 | Modelled | IHME |
| 366,046 (316,966 - 417,935) | 1993 | Modelled | IHME |
| 373,011 (323,787 - 424,672) | 1994 | Modelled | IHME |
| 381,434 (328,731 - 436,512) | 1995 | Modelled | IHME |
| 391,570 (338,901 - 447,365) | 1996 | Modelled | IHME |
| 403,475 (350,771 - 461,234) | 1997 | Modelled | IHME |
| 417,163 (363,644 - 478,697) | 1998 | Modelled | IHME |
| 432,571 (376,084 - 500,330) | 1999 | Modelled | IHME |
| 449,617 (390,925 - 522,398) | 2000 | Modelled | IHME |
| 466,608 (407,165 - 538,524) | 2001 | Modelled | IHME |
| 482,774 (420,411 - 556,831) | 2002 | Modelled | IHME |
| 499,442 (434,347 - 577,019) | 2003 | Modelled | IHME |
| 518,173 (447,883 - 599,078) | 2004 | Modelled | IHME |
| 540,767 (464,962 - 623,272) | 2005 | Modelled | IHME |
| 567,081 (488,792 - 653,403) | 2006 | Modelled | IHME |
| 596,145 (513,721 - 687,084) | 2007 | Modelled | IHME |
| 628,204 (543,801 - 725,031) | 2008 | Modelled | IHME |
| 663,662 (576,282 - 769,781) | 2009 | Modelled | IHME |
| 703,144 (609,598 - 818,304) | 2010 | Modelled | IHME |
| 745,749 (648,157 - 865,573) | 2011 | Modelled | IHME |
| 790,078 (687,230 - 906,753) | 2012 | Modelled | IHME |
| 836,389 (728,647 - 950,915) | 2013 | Modelled | IHME |
| 885,224 (768,966 - 1,004,220) | 2014 | Modelled | IHME |
| 937,424 (809,722 - 1,069,660) | 2015 | Modelled | IHME |
| 994,031 (861,686 - 1,138,210) | 2016 | Modelled | IHME |
| 1,051,540 (901,094 - 1,217,610) | 2017 | Modelled | IHME |
| 1,105,380 (954,817 - 1,281,290) | 2018 | Modelled | IHME |
| 1,155,830 (997,676 - 1,337,720) | 2019 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 7.25 (4.55 - 10.80) | 2019 | Modelled | IHME |
| 7.94 (5.13 - 11.70) | 2018 | Modelled | IHME |
| 8.24 (5.45 - 12.30) | 2017 | Modelled | IHME |
| 8.26 (5.42 - 12.30) | 2016 | Modelled | IHME |
| 8.26 (5.35 - 12.20) | 2015 | Modelled | IHME |
| 8.36 (5.39 - 12.40) | 2014 | Modelled | IHME |
| 8.37 (5.44 - 12.40) | 2013 | Modelled | IHME |
| 8.44 (5.54 - 12.50) | 2012 | Modelled | IHME |
| 8.62 (5.60 - 12.60) | 2011 | Modelled | IHME |
| 8.92 (5.79 - 12.80) | 2010 | Modelled | IHME |
| 9.17 (6.04 - 13) | 2009 | Modelled | IHME |
| 9.47 (6.26 - 13.60) | 2008 | Modelled | IHME |
| 9.99 (6.67 - 14.30) | 2007 | Modelled | IHME |
| 10.3 (6.87 - 14.60) | 2006 | Modelled | IHME |
| 10.7 (7.23 - 15.10) | 2005 | Modelled | IHME |
| 10.7 (7.20 - 15) | 2004 | Modelled | IHME |
| 10.9 (7.51 - 15.20) | 2003 | Modelled | IHME |
| 10.8 (7.39 - 15.20) | 2002 | Modelled | IHME |
| 10.8 (7.33 - 15.10) | 2001 | Modelled | IHME |
| 10.8 (7.23 - 15.20) | 2000 | Modelled | IHME |
| 10.8 (7.27 - 15.10) | 1999 | Modelled | IHME |
| 10.9 (7.28 - 15.20) | 1998 | Modelled | IHME |
| 10.9 (7.37 - 15.30) | 1997 | Modelled | IHME |
| 10.9 (7.39 - 15.20) | 1996 | Modelled | IHME |
| 11.2 (7.71 - 15.40) | 1995 | Modelled | IHME |
| 11.3 (7.76 - 15.60) | 1994 | Modelled | IHME |
| 11.4 (7.94 - 15.80) | 1993 | Modelled | IHME |
| 11.4 (7.99 - 15.80) | 1992 | Modelled | IHME |
| 11.5 (8.03 - 15.70) | 1991 | Modelled | IHME |
| 11.7 (8.20 - 15.90) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,688 (1,060 - 2,511) | 2019 | Modelled | IHME |
| 1,779 (1,150 - 2,623) | 2018 | Modelled | IHME |
| 1,777 (1,175 - 2,652) | 2017 | Modelled | IHME |
| 1,714 (1,125 - 2,546) | 2016 | Modelled | IHME |
| 1,649 (1,067 - 2,443) | 2015 | Modelled | IHME |
| 1,606 (1,036 - 2,380) | 2014 | Modelled | IHME |
| 1,549 (1,006 - 2,298) | 2013 | Modelled | IHME |
| 1,503 (986 - 2,219) | 2012 | Modelled | IHME |
| 1,478 (960 - 2,156) | 2011 | Modelled | IHME |
| 1,471 (955 - 2,106) | 2010 | Modelled | IHME |
| 1,455 (958 - 2,057) | 2009 | Modelled | IHME |
| 1,446 (956 - 2,076) | 2008 | Modelled | IHME |
| 1,467 (980 - 2,108) | 2007 | Modelled | IHME |
| 1,463 (971 - 2,068) | 2006 | Modelled | IHME |
| 1,459 (983 - 2,053) | 2005 | Modelled | IHME |
| 1,402 (944 - 1,965) | 2004 | Modelled | IHME |
| 1,376 (948 - 1,922) | 2003 | Modelled | IHME |
| 1,316 (899 - 1,844) | 2002 | Modelled | IHME |
| 1,268 (858 - 1,770) | 2001 | Modelled | IHME |
| 1,216 (815 - 1,711) | 2000 | Modelled | IHME |
| 1,178 (790 - 1,646) | 1999 | Modelled | IHME |
| 1,144 (763 - 1,598) | 1998 | Modelled | IHME |
| 1,106 (745 - 1,543) | 1997 | Modelled | IHME |
| 1,066 (721 - 1,482) | 1996 | Modelled | IHME |
| 1,057 (727 - 1,456) | 1995 | Modelled | IHME |
| 1,027 (708 - 1,422) | 1994 | Modelled | IHME |
| 1,007 (700 - 1,396) | 1993 | Modelled | IHME |
| 977 (682 - 1,347) | 1992 | Modelled | IHME |
| 949 (665 - 1,299) | 1991 | Modelled | IHME |
| 935 (658 - 1,279) | 1990 | Modelled | IHME |
| 2,029 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 51 (43 - 60) | 2019 | Modelled | IHME |
| 53 (44 - 61) | 2018 | Modelled | IHME |
| 53 (44 - 62) | 2017 | Modelled | IHME |
| 53 (45 - 62) | 2016 | Modelled | IHME |
| 53 (45 - 61) | 2015 | Modelled | IHME |
| 53 (45 - 61) | 2014 | Modelled | IHME |
| 53 (45 - 62) | 2013 | Modelled | IHME |
| 53 (45 - 62) | 2012 | Modelled | IHME |
| 53 (45 - 62) | 2011 | Modelled | IHME |
| 54 (45 - 62) | 2010 | Modelled | IHME |
| 54 (45 - 62) | 2009 | Modelled | IHME |
| 54 (45 - 62) | 2008 | Modelled | IHME |
| 54 (45 - 62) | 2007 | Modelled | IHME |
| 54 (46 - 62) | 2006 | Modelled | IHME |
| 54 (46 - 62) | 2005 | Modelled | IHME |
| 54 (46 - 63) | 2004 | Modelled | IHME |
| 54 (46 - 63) | 2003 | Modelled | IHME |
| 54 (46 - 63) | 2002 | Modelled | IHME |
| 55 (46 - 63) | 2001 | Modelled | IHME |
| 54 (46 - 63) | 2000 | Modelled | IHME |
| 54 (46 - 63) | 1999 | Modelled | IHME |
| 55 (46 - 63) | 1998 | Modelled | IHME |
| 55 (46 - 63) | 1997 | Modelled | IHME |
| 55 (46 - 63) | 1996 | Modelled | IHME |
| 55 (46 - 63) | 1995 | Modelled | IHME |
| 55 (46 - 63) | 1994 | Modelled | IHME |
| 55 (46 - 63) | 1993 | Modelled | IHME |
| 55 (46 - 63) | 1992 | Modelled | IHME |
| 55 (46 - 64) | 1991 | Modelled | IHME |
| 55 (46 - 64) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 79 | 2018 | Survey/reported | WHO/UNICEF |
| 85 | 2017 | Survey/reported | WHO/UNICEF |
| 80 | 2016 | Survey/reported | WHO/UNICEF |
| 84 | 2015 | Survey/reported | WHO/UNICEF |
| 81 | 2014 | Survey/reported | WHO/UNICEF |
| 73 | 2013 | Survey/reported | WHO/UNICEF |
| 71 | 2012 | Survey/reported | WHO/UNICEF |
| 75 | 2011 | Survey/reported | WHO/UNICEF |
| 70 | 2010 | Survey/reported | WHO/UNICEF |
| 71 | 2009 | Survey/reported | WHO/UNICEF |
| 81 | 2019 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 2.73 (2.16 - 3.42) | 2019 | Modelled | IHME |
| 2.73 (2.18 - 3.44) | 2018 | Modelled | IHME |
| 2.73 (2.18 - 3.46) | 2017 | Modelled | IHME |
| 2.73 (2.17 - 3.44) | 2016 | Modelled | IHME |
| 2.73 (2.17 - 3.46) | 2015 | Modelled | IHME |
| 2.74 (2.19 - 3.49) | 2014 | Modelled | IHME |
| 2.76 (2.21 - 3.50) | 2013 | Modelled | IHME |
| 2.79 (2.23 - 3.54) | 2012 | Modelled | IHME |
| 2.82 (2.25 - 3.58) | 2011 | Modelled | IHME |
| 2.85 (2.27 - 3.61) | 2010 | Modelled | IHME |
| 2.87 (2.29 - 3.64) | 2009 | Modelled | IHME |
| 2.89 (2.31 - 3.66) | 2008 | Modelled | IHME |
| 2.92 (2.32 - 3.68) | 2007 | Modelled | IHME |
| 2.94 (2.34 - 3.72) | 2006 | Modelled | IHME |
| 2.96 (2.36 - 3.76) | 2005 | Modelled | IHME |
| 2.99 (2.38 - 3.79) | 2004 | Modelled | IHME |
| 3.01 (2.41 - 3.80) | 2003 | Modelled | IHME |
| 3.04 (2.43 - 3.84) | 2002 | Modelled | IHME |
| 3.07 (2.45 - 3.88) | 2001 | Modelled | IHME |
| 3.09 (2.46 - 3.92) | 2000 | Modelled | IHME |
| 3.11 (2.49 - 3.92) | 1999 | Modelled | IHME |
| 3.13 (2.52 - 3.95) | 1998 | Modelled | IHME |
| 3.15 (2.53 - 3.95) | 1997 | Modelled | IHME |
| 3.17 (2.55 - 3.97) | 1996 | Modelled | IHME |
| 3.18 (2.55 - 4.01) | 1995 | Modelled | IHME |
| 3.2 (2.56 - 4.03) | 1994 | Modelled | IHME |
| 3.22 (2.57 - 4.05) | 1993 | Modelled | IHME |
| 3.24 (2.57 - 4.07) | 1992 | Modelled | IHME |
| 3.25 (2.58 - 4.10) | 1991 | Modelled | IHME |
| 3.27 (2.58 - 4.13) | 1990 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.42 (1.17 - 1.60) | 2019 | Modelled | Dugan et al., 2021 |
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 262,272 (206,808 - 331,420) | 1990 | Modelled | IHME |
| 269,129 (213,176 - 339,542) | 1991 | Modelled | IHME |
| 276,285 (219,668 - 347,540) | 1992 | Modelled | IHME |
| 283,817 (226,362 - 357,184) | 1993 | Modelled | IHME |
| 291,760 (233,326 - 366,884) | 1994 | Modelled | IHME |
| 300,089 (240,700 - 378,329) | 1995 | Modelled | IHME |
| 308,903 (248,647 - 387,427) | 1996 | Modelled | IHME |
| 318,271 (255,651 - 399,028) | 1997 | Modelled | IHME |
| 328,052 (263,850 - 414,628) | 1998 | Modelled | IHME |
| 338,170 (270,563 - 426,438) | 1999 | Modelled | IHME |
| 348,533 (277,221 - 442,513) | 2000 | Modelled | IHME |
| 358,981 (287,257 - 454,007) | 2001 | Modelled | IHME |
| 369,521 (295,165 - 466,787) | 2002 | Modelled | IHME |
| 380,278 (303,595 - 479,994) | 2003 | Modelled | IHME |
| 391,449 (312,401 - 495,939) | 2004 | Modelled | IHME |
| 403,224 (321,160 - 511,404) | 2005 | Modelled | IHME |
| 415,583 (331,346 - 525,433) | 2006 | Modelled | IHME |
| 428,410 (340,839 - 540,425) | 2007 | Modelled | IHME |
| 441,702 (352,153 - 558,096) | 2008 | Modelled | IHME |
| 455,444 (362,957 - 577,645) | 2009 | Modelled | IHME |
| 469,521 (373,569 - 595,711) | 2010 | Modelled | IHME |
| 483,360 (386,148 - 613,537) | 2011 | Modelled | IHME |
| 496,901 (397,787 - 629,388) | 2012 | Modelled | IHME |
| 511,010 (408,025 - 647,463) | 2013 | Modelled | IHME |
| 526,703 (420,338 - 670,297) | 2014 | Modelled | IHME |
| 545,108 (433,987 - 690,049) | 2015 | Modelled | IHME |
| 566,579 (450,712 - 714,579) | 2016 | Modelled | IHME |
| 589,283 (469,229 - 745,898) | 2017 | Modelled | IHME |
| 611,993 (489,057 - 770,702) | 2018 | Modelled | IHME |
| 635,075 (503,390 - 796,387) | 2019 | Modelled | IHME |
| 96,594 (77,904 - 120,269) | 1990 | Modelled | IHME |
| 96,597 (78,082 - 120,562) | 1991 | Modelled | IHME |
| 96,946 (78,565 - 120,999) | 1992 | Modelled | IHME |
| 97,758 (79,113 - 121,884) | 1993 | Modelled | IHME |
| 99,138 (80,142 - 123,455) | 1994 | Modelled | IHME |
| 101,207 (81,508 - 125,848) | 1995 | Modelled | IHME |
| 104,193 (84,122 - 129,621) | 1996 | Modelled | IHME |
| 108,090 (87,179 - 134,584) | 1997 | Modelled | IHME |
| 112,653 (91,026 - 140,580) | 1998 | Modelled | IHME |
| 117,589 (94,791 - 147,025) | 1999 | Modelled | IHME |
| 122,559 (98,672 - 153,351) | 2000 | Modelled | IHME |
| 126,656 (101,960 - 159,044) | 2001 | Modelled | IHME |
| 129,645 (103,925 - 162,298) | 2002 | Modelled | IHME |
| 132,200 (105,360 - 165,646) | 2003 | Modelled | IHME |
| 135,121 (107,459 - 169,142) | 2004 | Modelled | IHME |
| 139,363 (110,715 - 174,681) | 2005 | Modelled | IHME |
| 145,109 (115,189 - 182,727) | 2006 | Modelled | IHME |
| 151,834 (120,517 - 191,098) | 2007 | Modelled | IHME |
| 159,412 (126,712 - 200,768) | 2008 | Modelled | IHME |
| 167,699 (133,600 - 211,839) | 2009 | Modelled | IHME |
| 176,529 (140,544 - 223,335) | 2010 | Modelled | IHME |
| 185,338 (147,795 - 234,645) | 2011 | Modelled | IHME |
| 193,871 (154,953 - 243,815) | 2012 | Modelled | IHME |
| 202,548 (162,163 - 253,829) | 2013 | Modelled | IHME |
| 211,997 (170,120 - 266,007) | 2014 | Modelled | IHME |
| 223,076 (178,145 - 279,736) | 2015 | Modelled | IHME |
| 235,631 (187,138 - 295,567) | 2016 | Modelled | IHME |
| 249,511 (196,453 - 313,669) | 2017 | Modelled | IHME |
| 264,780 (208,574 - 334,519) | 2018 | Modelled | IHME |
| 280,935 (221,812 - 359,547) | 2019 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 69,600 (57,100 - 78,100) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 1.01 (0.61 - 1.65) | 2019 | Modelled | IHME |
| 0.97 (0.60 - 1.59) | 2018 | Modelled | IHME |
| 0.96 (0.58 - 1.57) | 2017 | Modelled | IHME |
| 0.94 (0.56 - 1.49) | 2016 | Modelled | IHME |
| 0.92 (0.55 - 1.46) | 2015 | Modelled | IHME |
| 0.93 (0.56 - 1.47) | 2014 | Modelled | IHME |
| 0.94 (0.57 - 1.46) | 2013 | Modelled | IHME |
| 0.95 (0.57 - 1.47) | 2012 | Modelled | IHME |
| 0.98 (0.59 - 1.52) | 2011 | Modelled | IHME |
| 1.01 (0.61 - 1.56) | 2010 | Modelled | IHME |
| 1.04 (0.63 - 1.60) | 2009 | Modelled | IHME |
| 1.07 (0.65 - 1.65) | 2008 | Modelled | IHME |
| 1.12 (0.70 - 1.69) | 2007 | Modelled | IHME |
| 1.15 (0.73 - 1.72) | 2006 | Modelled | IHME |
| 1.19 (0.75 - 1.75) | 2005 | Modelled | IHME |
| 1.19 (0.75 - 1.77) | 2004 | Modelled | IHME |
| 1.23 (0.78 - 1.83) | 2003 | Modelled | IHME |
| 1.24 (0.79 - 1.84) | 2002 | Modelled | IHME |
| 1.26 (0.81 - 1.85) | 2001 | Modelled | IHME |
| 1.27 (0.80 - 1.89) | 2000 | Modelled | IHME |
| 1.28 (0.82 - 1.90) | 1999 | Modelled | IHME |
| 1.29 (0.82 - 1.90) | 1998 | Modelled | IHME |
| 1.3 (0.84 - 1.92) | 1997 | Modelled | IHME |
| 1.3 (0.84 - 1.96) | 1996 | Modelled | IHME |
| 1.34 (0.86 - 2.03) | 1995 | Modelled | IHME |
| 1.35 (0.86 - 2.04) | 1994 | Modelled | IHME |
| 1.37 (0.87 - 2.08) | 1993 | Modelled | IHME |
| 1.38 (0.86 - 2.11) | 1992 | Modelled | IHME |
| 1.39 (0.87 - 2.14) | 1991 | Modelled | IHME |
| 1.42 (0.88 - 2.18) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 236 (142 - 383) | 2019 | Modelled | IHME |
| 218 (134 - 355) | 2018 | Modelled | IHME |
| 206 (126 - 338) | 2017 | Modelled | IHME |
| 194 (117 - 309) | 2016 | Modelled | IHME |
| 183 (110 - 292) | 2015 | Modelled | IHME |
| 179 (107 - 282) | 2014 | Modelled | IHME |
| 173 (104 - 270) | 2013 | Modelled | IHME |
| 169 (101 - 261) | 2012 | Modelled | IHME |
| 168 (101 - 261) | 2011 | Modelled | IHME |
| 167 (100 - 257) | 2010 | Modelled | IHME |
| 165 (100 - 254) | 2009 | Modelled | IHME |
| 163 (99 - 251) | 2008 | Modelled | IHME |
| 164 (103 - 248) | 2007 | Modelled | IHME |
| 162 (103 - 243) | 2006 | Modelled | IHME |
| 162 (103 - 238) | 2005 | Modelled | IHME |
| 156 (98 - 232) | 2004 | Modelled | IHME |
| 155 (98 - 230) | 2003 | Modelled | IHME |
| 150 (95 - 224) | 2002 | Modelled | IHME |
| 147 (94 - 216) | 2001 | Modelled | IHME |
| 143 (91 - 213) | 2000 | Modelled | IHME |
| 139 (89 - 207) | 1999 | Modelled | IHME |
| 135 (86 - 199) | 1998 | Modelled | IHME |
| 131 (84 - 194) | 1997 | Modelled | IHME |
| 127 (81 - 191) | 1996 | Modelled | IHME |
| 126 (81 - 191) | 1995 | Modelled | IHME |
| 123 (78 - 186) | 1994 | Modelled | IHME |
| 121 (77 - 183) | 1993 | Modelled | IHME |
| 118 (73 - 180) | 1992 | Modelled | IHME |
| 115 (72 - 177) | 1991 | Modelled | IHME |
| 114 (70 - 175) | 1990 | Modelled | IHME |
| 459 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 18 (12 - 25) | 2019 | Modelled | IHME |
| 17 (12 - 24) | 2018 | Modelled | IHME |
| 17 (11 - 23) | 2017 | Modelled | IHME |
| 17 (11 - 24) | 2016 | Modelled | IHME |
| 17 (11 - 24) | 2015 | Modelled | IHME |
| 17 (12 - 24) | 2014 | Modelled | IHME |
| 17 (12 - 24) | 2013 | Modelled | IHME |
| 17 (12 - 24) | 2012 | Modelled | IHME |
| 17 (12 - 24) | 2011 | Modelled | IHME |
| 17 (12 - 24) | 2010 | Modelled | IHME |
| 17 (12 - 24) | 2009 | Modelled | IHME |
| 17 (12 - 24) | 2008 | Modelled | IHME |
| 17 (12 - 23) | 2007 | Modelled | IHME |
| 17 (12 - 23) | 2006 | Modelled | IHME |
| 17 (12 - 23) | 2005 | Modelled | IHME |
| 17 (11 - 23) | 2004 | Modelled | IHME |
| 17 (11 - 23) | 2003 | Modelled | IHME |
| 17 (12 - 23) | 2002 | Modelled | IHME |
| 17 (12 - 23) | 2001 | Modelled | IHME |
| 17 (12 - 23) | 2000 | Modelled | IHME |
| 17 (11 - 23) | 1999 | Modelled | IHME |
| 17 (11 - 23) | 1998 | Modelled | IHME |
| 17 (12 - 23) | 1997 | Modelled | IHME |
| 17 (12 - 23) | 1996 | Modelled | IHME |
| 17 (11 - 23) | 1995 | Modelled | IHME |
| 17 (12 - 23) | 1994 | Modelled | IHME |
| 17 (11 - 23) | 1993 | Modelled | IHME |
| 17 (11 - 23) | 1992 | Modelled | IHME |
| 17 (11 - 23) | 1991 | Modelled | IHME |
| 17 (11 - 23) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
3.29
(%)
2019, latest modelled
(2.77 - 3.72(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines